Past Speakers
13-16 October 2025
RAI Congress Centre, Amsterdam
Kristyn Aalto, CEO, Orlance, Inc.
Fanny Abate, Global Clinical Team Manager Associate Director, PPD, part of Thermo Fisher Scientific
Sultan Abduljawad, Global Scientific Affairs Advisor, BioNTech
Mina Adel, Consultant - Global Access, Global Alliance and Product Optimization, IAVI
Holy Akwar, Deputy Head of Department, AMR & Vet Products, World Organization for Animal Health (WOAH)
Jeffrey Almond, Former VP Discovery R&D, Sanofi & Visiting Professor, University of Oxford - Oxford Vaccine Group
Pedro L. Alonso, SVP & Head of Global Health Office, BioNTech
Maria Alriksson, CEO, Abera Bioscience AB
Jean-Pierre Amorij, Vaccine Technology Specialist, UNICEF
William Ampofo, Executive Director, African Vaccine Manufacturing Initiative
Marta Antunes, Director, EU EMEA CMC Regulatory Affairs, MSD
Hala Audi, Chief Alliance Officer, Univercells
Kelli Aufderheide, Director of Lab Decentralized Trial Solutions, IQVIA Laboratories
Luigi Aurisicchio, CEO, Neomatrix
Shobana Balasingam, Research Lead, Human Investigations & Challenge, Wellcome Trust
Monika Ballmann, Associate Director, Viral Vector and Vaccine Development Department, Batavia Biosciences
Mario Barro, President / CEO, GIVAX Inc.
Kaidre Bendjama, CSO, NEC OncoImmunity AS
Joffrey Benford, SES, Director of CMA, and Deputy Head of Contracting Activity ASPR, HHS, HHS, ASPR, BARDA, CMA
Hamilton Bennett, Sr. Director Vaccine Access and Partnerships, Moderna
Francesco Berlanda Scorza, Director GVGH, GSK Vaccines for Global Health (GVGH)
Adam Bertelsen, CSO, adaptvac
Edouard Betsem A Betsem, Medical Director, Infectious Diseases and Vaccines, PAREXEL International
Sumi Biswas, Associate Professor, Jenner Institute, University of Oxford & President and CSO, Spybiotech Limited
Ulf Niklas Blomberg, Executive Director, Innovative Health Initiative
Cedric Bogaert, Chief Executive Officer, myNEO Therapeutics
Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine
Elena Bozzola, Paediatric Consultant, Bambino Gesù Children Hospital
Christian Brander, PI, Irsicaixa Research Institute
Gabrielle Breugelmans, Director of Epidemiology and Data Science, CEPI
Luigi Buonaguro, Lab Director, Istituto Nazionale Tumori "Pascale"
Nicolas Burdin, Global Head of R&D, Clover Pharma
David Burkhart, COO, Inimmune Corp
Christopher Bussineau, Principal Consultant, Biologics Consulting Group, Inc.
Maya Cabot, Senior Product Manager, Integral Molecular
Michael Caldwell, Assoc VP Vaccine Research, Meharry Medical College
Nathalia Cañón, Commercial Analyst, Vaxtrials
Juliana Cassataro, Professor, University of San Martin
Andrew Catchpole, CSO, hVIVO
Marco Cavaleri, Head of Public Health Threats, European Medicines Agency
Denis Cavert, Chief Executive Officer, Vaxxel
Ajoy Chakrabarti, Portfolio And Platform Lead, The Bill & Melinda Gates Foundation
Valerie Chambard, Supply Chain Lead, CEPI
Lucy Chappell, Chief Scientific Adviser, UK Department of Health and Social Care
Jean-Louis Charlier, Senior Specialist, Vaccine Distribution & Cold Chain, GSK
Sudha Chivukula, Head Discovery Biology, Sanofi
Robert Choy, Director of Research and Development, PATH
Dennis Christensen, Head of Global R&D, Croda Pharma
Javier Cid, Senior Research Scientist, Real-World Evidence, Evidera, part of the PPD clinical research business of Thermo Fisher Scientific
Margherita Coccia, Director, GSK
Wayland Coker, Chief Supply Chain Strategist, Dept of Health & Human Services/ASPR
Tim Cooke, CEO, Omniose
Chad Costley, Chief Executive Officer, BlueWillow Biologics, Inc.
James Cummings, Chief Medical Officer, Vaxart
Montse Daban, Director of Strategic Foresight and International Relations, BIOCAT
Christine Dahlke, Translational Immunology Lead, CEPI
Nader Daoud, Associate Director, Clinical Trial Health Equity, Moderna
Laurent Dapremont, Chief Executive Officer, Technovalia
Kashmira Date, Senior Director, Medical & Scientific Affairs, pfizer
Wian de Jongh, Chief Executive Officer, adaptvac
Stefaan De Koker, VP technology and innovation, etherna
Ingrid de Visser-Kamerling, Associate Research Director, Stichting Centre for Human Drug Research
Justin Devine, CIO, Synexa Life Sciences
Gianmarco Di Mauro, Business development, Teamit Institute
Valentina Di Salvatore, Doctor, University of Catania
Kyle Doolan, Director of Research, Integral Molecular
Helge Dorfmuller, Principal Investigator, University of Dundee
Denise Dubois, Project Officer, GF-TADs Coordination, World Organization for Animal Health (WOAH)
Alex Dulovic, Group Leader, NMI
Mark Emalfarb, Chief Executive Officer, Dyadic International Inc
Jaime Espin, Professor, Andalusian School Of Public Health
Marlene Espinoza, Director and Product Development Team Leader, International AIDS Vaccine Initiative (IAVI)
Rosaria Esposito, Global Field Scientist VaxArray®, bioMérieux
Nicola Esposito, QC Molecular Biology Assays Manager, Advaxia Biologics
Aaron Esser-Kahn, Professor, University of Chicago
Jay Evans, Chief Scientific and Strategy Officer, Inimmune
Jack Evans, Vice President, Site Operations, EmVenio Research
Katie Ewer, Senior Project Leader, Malaria vaccines, GSK
Tsong Fang, Data Scientist II, Julius Clinical
David Farcas, Director, Chile, Yelcho
Saul Faust, Prof of Paediatric Immunology & Infectious Diseases, University of Southampton
Eric Fevre, Research Fellow and Zoonoses Group Leader, ILRI & Chair of Veterinary Infectious Diseases, University of Liverpool & International Livestock Research Institute
Ricarda Finnern, CSO, LenioBio GmbH
Brendan Fish, Director of Biologics and RNA Centre of Excellence, C.P.I.
Brayden Fraser, Chief Development Officer, Emeritus Research
Alec Freyn, Principal Scientist, Moderna
Bernard Fritzell, Independent Consultant, TuBerculosis Vaccine Initiative
Antonio Garcia Maldonado, Investment Professional, Strategic Investment Fund, Bill and Melinda Gates Foundation
Dagmar Garcia Rivera, R&D vicedirector, Finlay Vaccine Institute
Dean Geribo, Vice President, Corporate Security, Moderna
Trang Gisler, Senior Director, Government and Public Health Services, PPD, part of Thermo Fisher Scientific
Andrew Goldsborough, ceo, RNAssist
Nicola Groth, Chief Medical Officer, Osivax
Marion Gruber, Vice President of Public Health and Regulatory Affairs, IAVI
Andrea Guerra, Regional Clinical Director, Vaccines, Europe, MSD
Swati Gupta, VP, Head of Emerging Infectious Diseases and Epidemiology, International AIDS Vaccine Initiative
Yper Hall, Head of Pre-Clinical Evaluation, UK Health Security Agency (UKHSA)
Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UK Health Security Agency
Martina Hampel, Dr, KyooBe Tech GmbH
Elie Hanania, VP Process Development Viral Vectors, Avid Bioservices
Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization
Thomas Hauser, Sales Director EMEA, C-Cube
Jonathan Luke Heeney, CSO, DIOSynVax Ltd
Ana Maria Henao-Restrepo, Co-Lead R&D Blueprint for epidemics, Health Emergencies Programme (WHE),, World Health Organisation
Jenny Hendriks, Head Biomarkers and Clinical Immunology, Janssen Vaccines & Prevention B.V.
Susan Hepworth, Executive Director, National Coalition for Infant Health
Holger Heyn, Co-Founder & CSO, Omniscope
Catherine Hoath, Global Regulatory Strategy Lead, CEPI
Andre Hoekema, Chief Business Officer, Transmucosis
Talita Honorato-Rzeszewicz, Associate Grant Officer, Global Medical Grants and Partnerships; Institute of Translational Equitable Medicine, pfizer
Mark Howarth, Sheild Chair of Pharmacology, University Of Cambridge
Robert Huebner, Principal Consultant, Latham BioPharm Group
Andreea Iordache, Manager, Science & Regulatory Affairs, Vaccines Europe
Antoine Jacquot, Head of Distribution Sales EMEA & APAC, Advanced Instruments, TECIL S.A.
Ashish Jha, Dean, Brown University School of Public Health
Jose Jimeno, CEO, Vaxtrials
Karin Jooss, EVP & Head of R&D, Gritsone bio
Arlene Joyner, Director, Office of Industrial Base Management and Supply Chain (IBMSC),, HHS/.ASPR/IBMSC
Emilie Karafillakis, European Director, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine
Nektaria Karavas, Business Development Director, Aptar Pharma
Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.
Edward Kelley, Chief Global Health Officer, ApiJect
Chase Kempinski, Chief Executive Officer, EVAX Inc.
Cari Kessing, Director, Laboratory Operations, IQVIA Laboratories
Lakshmi Khandke, Senior Program Advisor, PATH
PJ Kim, Vice President, Business Development, ApiJect
Jerome Kim, Director General, IVI
Maria Koufali, Programme Director, UK Vaccine Innovation Pathway
Michael Kowarik, CSO, LimmaTech Biologics AG
Leyla Kragten-Tabatabaie, Director ReSViNET, Julius Clinical Research B.V.
Inca Kusters, Senior Director External R&D, Sanofi's Vaccines division
Jonathan Kwok, Chief Executive Officer, Infinitopes
Marcus Lacey, Exec Director Global Pandemic, CSL Seqirus
Randy Lacey, Field Application Scientist, InDevR
Gemma Lahuerta, Parenteral Development Director, LABORATORIO REIG JOFRE, S.A.
Teresa Lambe, Calleva Head of Vaccine Immunology & Professor of Vaccinology & Immunology, University of Oxford
Nathalie Landry, Chief Scientific Officer, PharmaJet
Dominic Larkin, Therapeutic Strategy Director, IQVIA
Jae Myun Lee, Scientific Advisor, Yonsei University
Geert Leroux Roels, Professor Emeritus, Gent University
Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital
Dave Liebowitz, Senior Vice President, Early-Stage Clinical Development, Inovio
Megan Livingston, Vice President, Business Development, Jurata Thin Film, Inc.
Stephen Lockhart, Director, Senior Consultant, HURST GRANGE ASSOCIATES
Vincent Loh, Senior Director Global Regulatory Affairs CMC Infectious Diseases, BioNTech
Adolfo Lopez, Production Director, CZ Vaccines
James Love, Director, Knowledge Ecology International
Donald Loveday, Head Of Business Development, SPI Pharma Inc
Mats Lundgren, CSO, Abera Bioscience AB
Marie-Louise Lunn, Senior Product Manager, Novo Nordisk Pharmatech
Riks Maas, Head of Department of Virology, Wageningen Bioveterinary Research (WBVR)
Sunil Maharjan, Principal Scientist, NIBSC, Medicines and Healthcare Regulatory Agency
Enrique Mañán, Chief of Staff, Contracts Division, US DHHS, BARDA
Alessandro Manenti, Chief Development Officer, Vismederi
Silvana Marangon, Director of Operations, Integra IT
Cinzia Marano, Executive Director, Medical Affairs, EMEC region, Moderna
Gerben Marsman, Head of Alliance Management, Vaccine Formulation Institute
Tyler Martin, CEO, Great Plains Biotechnology & Adjuvance Technologies
Federico Martinon-Torres, Head of Pediatrics, Hospital Clínico Universitario de Santiago
Shelley Mclendon, Senior Vice President, Vaccine and Infectious Disease, ICON Clinical Research LLC’
Donald McVinnie, Director, Medical Monitor, Vaccine Clinical R&D, Pfizer
Vasily Medvedev, Head of Development, Exothera
Nupur Mehrotra, Co-founder & Director-Operations, Premas Biotech
Federico Mensa, Vice President, Clinical Development, Infectious Disease, BioNTech
Narcisa Mesaros, VP, Medical Science & Strategy, PPD clinical research business of Thermo Fisher Scientific
Florence Meunier, Therapeutic Area Head, Global Regulatory Affairs, Sanofi
Romain Micol, Chief Executive Officer, Combined Therapeutics
Nikki Miller, Senior Therapeutic Strategy Manager, Novotech
Chris Minchell, Deputy Director - Strategy, UKHSA
Rachel Mitrovich, Director, Global Vaccines Policy Strategy & Partnerships, MSD
Lenny Moise, VP, Research, SeromYx
Anne Moore, NIBRT PI, University Colleague Cork
Alexandra Moros, R&D Researcher and Project Leader at HIPRA Human Health, Hipra
Berit Muller-Pebody, Scientific Head of Antimicrobial Resistance & Prescribing, UKHSA
Kilian Mullet, Senior Director , Commercial supply strategy, Pfizer Global Supply, pfizer
Matthias Müllner, CEO, bespark*bio
Rasmus Münter, Lead Research Scientist, Adjuvant Systems, Croda Pharma
Marta Murreddu, Business Development Manager, Cerba Research
Irene Nkumama, Malaria Programme Manager, European Vaccine Initiative (EVI)
Hanna Nohynek, Chief Physician, National Institute for Health and Welfare
Elizabeth Norton, Associate Professor, Tulane University
Kate O' Dwyer, Process Development Engineer, Apc
Isabel Oliver, Director General of Science & Research and Chief Scientific Officer, UK Health Security Agency
Jorge Osorio, Chief Executive Officer, Vaxthera
Ab Osterhaus, Director of Research Center For Emerging Infections and Zoonoses and Professor, University of Veterinary Medicine Hannover
Rodrigo Otero, Vice President, Desert King
Serge Pampfer, CEO, Lovaltech
Francesco Pappalardo, Deputy Director, Department of Drug and Health Sciences, University of Catania
Robert Paris, VP, Infectious Diseases Development, Moderna
Karina Pasquevich, researcher, UNSAM
Martin Pech, Senior Manager Development & Head of Production CTM, IDT Biologika
Tim Peterson, Scientific Director, Dermal Drug Delivery, Kindeva Drug Delivery
Wolfgang Philipp, Principal Adviser, Chief Science Officer, European Commission Health Emergency Preparedness & Response (HERA)
Haiko Pillu, Director Operations CPU, SGS
Dirk Poelaert, Head of Medical Affairs Europe, NOVAVAX
Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Executive Advisor
Asaf Poran, Senior Director, Systems immunology, BioNTech
Mukul Pore, Executive Director, Intox Pvt Ltd
Marco Pravetoni, Center Director & Rick L. Seaver Endowed Professor of Psychiatry, University of Washington School of Medicine
Carine Punt, CEO, bunyavax
Sibilia Quilici, Executive Director, Vaccines Europe
Martin Rabel, Global Sales Specialist | Biopharma Services, Cytiva
Trina Racine, Director Vaccine Development, Vaccine and Infectious Disease Organization (VIDO)
Sankarasubramanian Rajaram, Head of Global Medical Strategy, Seqirus
Cristina Rebordosa, Senior Director of Epidemiology, RTI Health Solutions
Fabio Riefolo, Medicines research & regulatory science advisor, Teamit Institute
Giovanna Riggall, Head of Heath Supply Chain, Unimed
Ruben Rizzi, SVP Global Regulatory Affairs, BioNTech SE
Meta Roestenberg, Clinical Head, Controlled Human Infection Center, Leiden University Medical Center (Netherlands)
Christine Rollier, Professor of Vaccinology, University of Surrey
Thierry Rolling, Director, Clinical Development Infectious Diseases, BioNTech SE
Nikki Romanik, Special Assistant to the President, Deputy Director and Chief of Staff, The White House
Simona Rondini, Head Bacterial Projects and Senior Project Leader, GSK Vaccines
Birgitte Rønø, Chief Scientific Officer, Evaxion Biotech A/S
Sarah Rosen, Senior Director, Non-Interventional Studies, Evidera part of the PPD clinical research business of Thermo Fisher Scientific
Zeil Rosenberg, Executive Vice President, Medical, Tonix Pharmaceuticals
Gaëtane Rouvray, Director CMC, Lovaltech on behalf of GTPBioways
Andres Rozo, CEO - Executive Director, Vaccine eTools for Clinical Trials, INTEGRA IT SA
Olli Rundgren, CEO & Founder, Psyon Games
Kristyna Sala, Applications Scientist for Imaging & BioPharma, Molecular Devices
Jeremy Salt, Chief Executive Officer, The Vaccine Group
Avencia Sánchez-Mejías García, Chief Executive Officer, Integra Therapeutics
Tyler Sandberg, Product Manager, ELISpot & FluoroSpot, MABTECH
Volker Sandig, Chief Scientific Officer, ProBioGen AG
Delphine Saragoussi, Exec Director, Epidemiology and Scientific Affairs, Real-World Evidence, Peri- and Post-Approval, Evidera, part of the PPD clinical research business of Thermo Fisher Scientific
Niranjan Sardesai, President & Chief Executive Officer, Founder, Geneos Therapeutics
Melanie Saville, Chief Scientific Officer, PATH
Stefan Schreck, Adviser, Stakeholder Relations, Public Health, Cancer And Health Security Directorate, DG SANTE, European Commission
Alain Schuerwegen, Head of Sales - Global Delivery, SOFRIGAM GROUP
Claire Sears, Head of Business Transformation, EMS Healthcare
Maite Segurola, Head Life Sciences Portfolio, Cocoon Bioscience
Taylor Sexton, Executive Director, Medical Countermeasures Coaltion
Nitin Shetty, Chief Technical Officer, Bioneeds India Private Limited
Amy Shurtleff, Head of Animal Models, CEPI
Aleksandra Sikora, Professor, Oregon State University College of Pharmacy
Lucas Silva, Senior Specialist, Aptar Pharma
George Simeon, CEO, Curevo Vaccine
Joe Smyser, Chief Executive Officer, PGP (The Public Good Projects)
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Miriam Sturkenboom, Professor in RWE & Head, Department of DataScience and Biostatistics, University Medical Center Utrecht & President, VAC4EU
Vic Suarez, Principal Growth Partner, Blu Zone Bioscience
Miriam Taegtmeyer, Professor of Global Health, London School of Hygiene and Tropical Medicine
Mojca Tajnik Sbaizero, Head of Product-Application Area, Process Development Dept. for Viral Vectors and Vaccines, Sartorius BIA Separations
Andrea Tattersall, Director Laboratory Operations, Revvity
Stephen Taylor, Scientific Lead, Applied Pathogen Immunology, UKHSA
Nigel Temperton, Director, VPUbio Limited
Nigel Temperton, Professor and Director, University of Kent
Takaaki Terahara, Executive Officer Head of R&D Division, Hisamitsu Pharmaceuticals
Petro Terblanche, Chief Executive Officer, Afrigen Biologics (Pty) Ltd
Angus Thomson, Principal, Irimi
Thomas Trolle, Director, Bioinformatics & AI/ML, Evaxion Biotech
Jane True, VP, mRNA CSI & Global Pandemic Security Lead, Pfizer
Uta Tschiesner, Senior Director, Global Medical Affairs, BioNTech
Sean Tucker, CSO, Vaxart
Lance Turtle, Chair and Honorary Consultant Physician in Infectious Diseases; Deputy Head, Department of Clinical Infection, Microbiology and, University of Liverpool
Satoshi Uchida, Professor, Tokyo Medical and Dental University (TMDU)
Sebastian Ulbert, Deputy Director, Fraunhofer-Institute for Cell Therapy and Immunology
Andrew Ustianowski, Interim National Executive Director, Research Delivery Network, NIHR
Arno van der Ark, Project manager, Intravacc
Marc van Pruijssen, General Manager Clinical Trial Services & Logistic Excellence, Senior Vice-President Global Logistics and CTOS, Cerba Research
Nico Vandaele, Prof. dr., KU Leuven, Access-To-Medicines Research Centre
Joris Vandeputte, Past President, IABS
Vanessa Vankerckhoven, CEO, Idevax
Roland Ventura, VFI Senior Advisor for Strategy, Vaccine Formulation Institute
Ine Vercammen, Founder & CEO, Meclinas
Charlotte Vernhes, Director Scientific and Medical Affairs, Vaccines Europe
Felipe Villalobos Martínez, Scientific Coordinator, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol (IDIAP )
Carla Vinals, VP Head of Regulatory Strategy, Moderna
Cesar Vinces, Sr. Director Regulatory Innovation & International Policy, Accumulus Synergy
Thomas Waite, Deputy Chief Medical Officer, UK Department of Health
Eric Weaver, Professor, University of Nebraska Lincoln
Elissa Weitzman, Associate Professor, Director of Research, Boston Children's Hospital, and Harvard Medical School
Suzanne Welten, Scientific Manager Immunology, Johnson & Johnson
Gerald Wirnsberger, Head of Research And Development, Ribbon Biolabs GmbH
Daniel Wolfe, Deputy Direct, BARDA CBRN Medical Countermeasures, Biomedical Advanced Research And Development Authority
Edward Wright, President Government and Public Health Solutions, ICON PLC
Nicola Yallup, Head of Lifesciences, Partnership & Growth, NIHR
Xinhao Ye, Director of CMC Management, WuXi Vaccines
Roland Zahn, Senior Scientific Director - Head Preclinical Immunology - Viral Vaccines, Johnson & Johnson
Luca Zambelloni, Project Manager, Vaccines, Thermo Fisher Scientific
Heather Zar, Professor Department of Paediatrics and Child Health & Director, School of Child and Adolescent Health, University of cape town
Elvira Zini, Director of Scientific & Technical Affairs, Laboratorios Richmond SACIF
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events